eISSN: 2957-9716 / ISSN: 2957-9708
Register
Login
International Journal of Clinical Studies and Medical Research
2024, Volume 2, Issue 4 : 1-9
Research Article
Long-Term Clinical Effects of COVID-19
 ,
 ,
1
Department of Internal Medicine, Global Institute of Medical Sciences, Boston, USA
2
Department of Pulmonary and Critical Care Medicine, International Medical Sciences University, New Delhi, India
3
Center for Infectious Disease and Public Health Research, Metropolitan Health University, London, United Kingdom
Abstract

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2, has produced significant acute and long-term health consequences worldwide. A subset of individuals experience persistent, recurrent, or newly developed symptoms after acute infection, commonly described as long COVID or post-COVID-19 condition. The World Health Organization defines post-COVID-19 condition as symptoms usually beginning within three months of initial infection and lasting at least two months, often affecting daily activities. Long-term effects may involve respiratory, cardiovascular, neurological, psychological, metabolic, renal, gastrointestinal, and musculoskeletal systems. Common manifestations include fatigue, dyspnea, cognitive dysfunction, sleep disturbance, chest pain, palpitations, anxiety, depression, post-exertional symptom worsening, and reduced quality of life. This review examines the long-term clinical effects of COVID-19, proposed mechanisms, risk factors, diagnostic approaches, management strategies, and public health implications. Current evidence suggests that long COVID is heterogeneous, fluctuating, and clinically complex, requiring multidisciplinary care, symptom-directed treatment, rehabilitation, prevention of reinfection, vaccination, and continued research.

Keywords
License
Copyright (c) International Journal of Clinical Studies and Medical Research
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
Int. J. Clin. Stud. Med. Res. open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Recommended Articles
Nutritional Deficiencies Among School-Age Children
1-9
Clinical Characteristics of Multi-Drug Resistant Infections: Epidemiology, Risk Factors, Clinical Outcomes, and Emerging Management Strategies
1-6
Dengue Fever Management and Clinical Outcomes
1-6
Antibiotic Stewardship Programs in Healthcare Settings
1-5
International Journal of Clinical Studies and Medical Research
support@ijcsmr.co.ke
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives (CC BY-NC-ND) license. Open Access Publication.
Copyright © ©International Journal of Clinical Studies and Medical Research. All rights reserved.
|
|
|